⚠️ FOR RESEARCH PURPOSES ONLY — All compounds and data are for in vitro laboratory research and educational reference only. Not for human or animal use. Not evaluated by the FDA.
Research Library 28 Compounds

Research Peptide Blog Database

Peer-reviewed studies, clinical data, mechanism breakdowns, and molecular specifications — all in one place.

🔍
Research Library Gastric Peptide

Body Protection Compound · Pentadecapeptide

BPC-157

Pentadecapeptide for tissue repair research.

FormulaC62H98N16O22
Mol. Weight1419.55 g/mol
CAS137525-51-0
SequenceGly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
PubMed Indexed Research Use Only

Published Scientific Research

Peer-reviewed studies investigating BPC-157 sourced from PubMed-indexed journals for educational reference only.

Literature Review PubMed

Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing.

Cell and tissue research 2019
Gwyer D, Wragg NM, Wilson SL et al.

There is a current need for a therapy that can alleviate the social and economic burden that presents itself with debilitating and recurring musculoskeletal soft tissue injuries and disorders. Currently, several therapies are emerging and...

View Full Study on PubMed →
In Vivo Study PubMed

The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.

Journal of applied physiology (Bethesda, Md. : 1985) 2011
Chang CH, Tsai WC, Lin MS et al.

Pentadecapeptide BPC 157, composed of 15 amino acids, is a partial sequence of body protection compound (BPC) that is discovered in and isolated from human gastric juice. Experimentally it has been demonstrated to accelerate the...

View Full Study on PubMed →
Literature Review PubMed

BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing.

Current pharmaceutical design 2018
Seiwerth S, Rucman R, Turkovic B et al.

Commonly, the angiogenic growth factors signify healing. However, gastrointestinal ulceration is still poorly understood particularly with respect to a general pharmacological/pathophysiological role of various angiogenic growth factors implemented in growth factors wound healing concept. Thereby,...

View Full Study on PubMed →
Clinical Trial PubMed

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.

Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews 2026
Rahman OF, Lee SJ, Seeds WA et al.

Therapeutic peptides are emerging as promising adjuncts in the management of orthopaedic injuries, grounded in their ability to modulate molecular signaling networks central to cellular medicine. By acting on key pathways such as PI3K/Akt, mTOR,...

View Full Study on PubMed →
Literature Review PubMed

BPC 157 and blood vessels.

Current pharmaceutical design 2014
Seiwerth S, Brcic L, Vuletic LB et al.

This review focuses on the described effects of BPC 157 on blood vessels after different types of damage, and elucidate by investigating different aspects of vascular response to injury (endothelium damage, clotting, thrombosis, vasoconstriction, vasodilatation,...

View Full Study on PubMed →
Literature Review PubMed

Stable gastric pentadecapeptide BPC 157-NO-system relation.

Current pharmaceutical design 2014
Sikiric P, Seiwerth S, Rucman R et al.

We reviewed stable gastric pentadecapeptide BPC 157-NO-system-relation, its close participation in Moncada's (maintained vascular integrity, platelets control) homeostatic healing response of NO-system to injury. Namely, BPC 157's particular healing effect also affects all events after...

View Full Study on PubMed →
Research Article PubMed

Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract Healing.

Current pharmaceutical design 2018
Sikiric P, Rucman R, Turkovic B et al.

Years ago, we revealed a novel cytoprotective mediator, stable gastric pentadecapeptide BPC 157, particular anti-ulcer peptide that heals different organs lesions when given as a therapy, native in human gastric juice while maintaining GI-tract mucosal...

View Full Study on PubMed →
In Vivo Study PubMed

BPC 157's effect on healing.

Journal of physiology, Paris 1997
Seiwerth S, Sikiric P, Grabarevic Z et al.

The 15 amino acid agent BPC 157, showing a wide range of organoprotective action in different experimental models, was used in our experiments in order to establish its influence on different elements connected with the...

View Full Study on PubMed →
Research Notice: All studies are presented for educational and informational purposes only. These compounds are for in vitro laboratory research use only (RUO). Not for human or animal use. Not evaluated or approved by the FDA.
Compound Information

Technical Specifications

🔬 Molecular Profile

TypeGastric Peptide
ClassificationSynthetic Analog
CAS Number137525-51-0
Mol. Weight1419.55 g/mol
SequenceGly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
FormulaC62H98N16O22
OriginGastric juice

🧊 Storage Requirements

❄️
Lyophilized (powder) -20°C up to 2 years
💉
Reconstituted 2-8°C up to 30 days
⏱️
Working solution Use within 24 hours
Protect from light • Avoid repeated freeze-thaw cycles
Research Grade

Research-Grade BPC-157

≥98% purity, third-party COA verified, lyophilized for stability. For in vitro laboratory research use only.

⚠️ Research Use Only. Not for human or animal use. Not evaluated or approved by the FDA.

⚠️ Important Research Notice

All compounds listed are intended exclusively for in vitro laboratory research by qualified professionals. Not for human or animal consumption. Not approved by the FDA for any diagnostic, therapeutic, or clinical purpose. All research findings are sourced from peer-reviewed journals for educational reference only. Not to be interpreted as medical advice or product claims.